{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T16:10:04Z","timestamp":1784391004805,"version":"3.55.0"},"reference-count":390,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020374","name":"Ministry of AYUSH, Government of India","doi-asserted-by":"publisher","award":["3-67\/2022-CCRUM\/Tech"],"award-info":[{"award-number":["3-67\/2022-CCRUM\/Tech"]}],"id":[{"id":"10.13039\/100020374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030887","name":"Central Council for Research in Unani Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030887","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007334","name":"Ministry of Health and Family Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009104","name":"Department of Health Research","doi-asserted-by":"publisher","award":["R.12013\/27\/2024-HR"],"award-info":[{"award-number":["R.12013\/27\/2024-HR"]}],"id":[{"id":"10.13039\/501100009104","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ijbiomac.2025.148293","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T06:14:45Z","timestamp":1760336085000},"page":"148293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"P2","title":["Nano-conjugation of small molecule modulators of protein aggregation: Enhancing the therapeutic precision"],"prefix":"10.1016","volume":"331","author":[{"given":"Syed Ifrah","family":"Manzoor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishfaq Ahmad","family":"Ahanger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid Rasool","family":"Kamli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maqsood Ahmad","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanveer Ali","family":"Dar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2025.148293_bb0005","series-title":"models, molecules and mechanisms in biogerontology: cellular processes, Metabolism and Diseases","first-page":"419","article-title":"Protein aggregation, related pathologies, and aging","author":"Kar","year":"2020"},{"issue":"Suppl. 7","key":"10.1016\/j.ijbiomac.2025.148293_bb0010","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/nm1066","article-title":"Protein aggregation and neurodegenerative disease","volume":"10","author":"Ross","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0015","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.tma.2023.09.001","article-title":"Proteostasis defects: medicinal challenges of imperfect aging & neurodegeneration","volume":"7","author":"Kumar","year":"2023","journal-title":"Transl. Med. Aging"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0020","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s00109-003-0464-5","article-title":"Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution","volume":"81","author":"Stefani","year":"2003","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0025","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.ijbiomac.2019.05.109","article-title":"Protein misfolding, aggregation and mechanism of amyloid cytotoxicity: an overview and therapeutic strategies to inhibit aggregation","volume":"134","author":"Zaman","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0030","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bpc.2013.06.003","article-title":"The amyloid-cell membrane system. The interplay between the biophysical features of oligomers\/fibrils and cell membrane defines amyloid toxicity","volume":"182","author":"Cecchi","year":"2013","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molliq.2025.127626","article-title":"Impact of amino acid derivative osmolytes on structure-function integrity and aggregation propensity of catalase: implications for inefficient antioxidant defense in protein aggregation disorders","volume":"429","author":"Manzoor","year":"2025","journal-title":"J. Mol. Liq."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.148293_bb0040","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrd4593","article-title":"Targeting protein aggregation for the treatment of degenerative diseases","volume":"14","author":"Eisele","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148293_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.medp.2024.100005","article-title":"Targeting protein aggregation for the treatment of neurodegenerative diseases","volume":"1","author":"Li","year":"2024","journal-title":"Medicine Plus"},{"issue":"17","key":"10.1016\/j.ijbiomac.2025.148293_bb0050","doi-asserted-by":"crossref","first-page":"11269","DOI":"10.1021\/acs.chemrev.7b00077","article-title":"Small-molecule modulation of protein homeostasis","volume":"117","author":"Burslem","year":"2017","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0055","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cbpa.2017.06.008","article-title":"Small molecule probes of protein aggregation","volume":"39","author":"Young","year":"2017","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.arr.2024.102538","article-title":"Small molecule modulators of alpha-synuclein aggregation and toxicity: pioneering an emerging arsenal against Parkinson\u2019s disease","volume":"101","author":"Ahanger","year":"2024","journal-title":"Ageing Res. Rev."},{"issue":"24","key":"10.1016\/j.ijbiomac.2025.148293_bb0065","doi-asserted-by":"crossref","first-page":"10823","DOI":"10.1021\/jm301182j","article-title":"Small molecules that target protein misfolding","volume":"55","author":"Gavrin","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0070","series-title":"Targeting Trafficking in Drug Development","first-page":"85","article-title":"Targeting of disordered proteins by small molecules in neurodegenerative diseases","author":"Longhena","year":"2018"},{"issue":"52","key":"10.1016\/j.ijbiomac.2025.148293_bb0075","doi-asserted-by":"crossref","first-page":"32508","DOI":"10.1039\/C7RA03752J","article-title":"(\u2212)-Epigallocatechin-3-gallate (EGCG) inhibits fibrillation, disaggregates amyloid fibrils of \u03b1-synuclein, and protects PC12 cells against \u03b1-synuclein-induced toxicity","volume":"7","author":"Zhao","year":"2017","journal-title":"RSC Adv."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148293_bb0080","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1161\/CIRCULATIONAHA.118.037398","article-title":"Blood pressure\u2013lowering by the antioxidant resveratrol is counterintuitively mediated by oxidation of cGMP-dependent protein kinase","volume":"140","author":"Prysyazhna","year":"2019","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148293_bb0085","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1039\/D1CB00220A","article-title":"Phosphorylated resveratrol as a protein aggregation suppressor in vitro and in vivo","volume":"3","author":"Mehringer","year":"2022","journal-title":"RSC chemical biology"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0090","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ijbiomac.2019.06.050","article-title":"Human islet amyloid polypeptide (hIAPP) aggregation in type 2 diabetes: correlation between intrinsic physicochemical properties of hIAPP aggregates and their cytotoxicity","volume":"136","author":"Chaari","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.148293_bb0095","doi-asserted-by":"crossref","first-page":"9949","DOI":"10.3390\/molecules18089949","article-title":"Neuroprotective, anti-amyloidogenic and neurotrophic effects of apigenin in an Alzheimer\u2019s disease mouse model","volume":"18","author":"Zhao","year":"2013","journal-title":"Molecules"},{"issue":"21","key":"10.1016\/j.ijbiomac.2025.148293_bb0100","doi-asserted-by":"crossref","first-page":"11484","DOI":"10.3390\/ijms222111484","article-title":"Kaempferol has potent protective and antifibrillogenic effects for \u03b1-synuclein neurotoxicity in vitro","volume":"22","author":"Inden","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0105","article-title":"The neuroprotective effects of fisetin, a natural flavonoid in neurodegenerative diseases: focus on the role of oxidative stress","volume":"13","author":"Hassan","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148293_bb0110","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3390\/brainsci14010096","article-title":"Epigallocatechin-3-Gallate and Genistein for decreasing gut Dysbiosis, inhibiting Inflammasomes, and aiding autophagy in Alzheimer\u2019s disease","volume":"14","author":"Muraleedharan","year":"2024","journal-title":"Brain Sci."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148293_bb0115","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3390\/biom11050767","article-title":"Green tea epigallocatechin-3-gallate (EGCG) targeting protein misfolding in drug discovery for neurodegenerative diseases","volume":"11","author":"Gon\u00e7alves","year":"2021","journal-title":"Biomolecules"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148293_bb0120","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1096\/fj00-0294rev","article-title":"Roles of the heat shock transcription factors in regulation of the heat shock response and beyond","volume":"15","author":"Pirkkala","year":"2001","journal-title":"FASEB J."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.148293_bb0125","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/nrd3453","article-title":"Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseases","volume":"10","author":"Neef","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/5584_2022_742","article-title":"HSF1 and its role in Huntington\u2019s disease pathology","volume":"19","author":"Kim","year":"2022","journal-title":"Cell Biology and Translational Medicine, Volume 19: Perspectives in Diverse Human Diseases and Their Therapeutic Options"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148293_bb0135","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14405","article-title":"Abnormal degradation of the neuronal stress-protective transcription factor HSF1 in Huntington\u2019s disease","volume":"8","author":"Gomez-Pastor","year":"2017","journal-title":"Nat. Commun."},{"issue":"23","key":"10.1016\/j.ijbiomac.2025.148293_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252313121","article-title":"Overcoming challenges in small-molecule drug bioavailability: a review of key factors and approaches","volume":"25","author":"Wu","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.148293_bb0145","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1016\/j.apsb.2023.05.035","article-title":"Small molecules targeting protein\u2013protein interactions for cancer therapy","volume":"13","author":"Wu","year":"2023","journal-title":"Acta Pharm. Sin. B."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148293_bb0150","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.yexmp.2008.12.004","article-title":"Nanoparticle-based targeted drug delivery","volume":"86","author":"Singh","year":"2009","journal-title":"Exp. Mol. Pathol."},{"issue":"24","key":"10.1016\/j.ijbiomac.2025.148293_bb0155","doi-asserted-by":"crossref","first-page":"5963","DOI":"10.3390\/molecules25245963","article-title":"Cellular targeting of oligonucleotides by conjugation with small molecules","volume":"25","author":"Hawner","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0160","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.ijbiomac.2020.11.053","article-title":"Stability and refolding of Dihydrofolate reductase enhances with nano-conjugation","volume":"167","author":"Verma","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"13","key":"10.1016\/j.ijbiomac.2025.148293_bb0165","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1021\/bi00227a001","article-title":"Protein folding: local structures, domains, subunits, and assemblies","volume":"30","author":"Jaenicke","year":"1991","journal-title":"Biochemistry"},{"issue":"6294","key":"10.1016\/j.ijbiomac.2025.148293_bb0170","doi-asserted-by":"crossref","first-page":"aac4354","DOI":"10.1126\/science.aac4354","article-title":"In vivo aspects of protein folding and quality control","volume":"353","author":"Balchin","year":"2016","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148293_bb0175","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s41467-023-36496-y","article-title":"Cell surface protein aggregation triggers endocytosis to maintain plasma membrane proteostasis","volume":"14","author":"Paul","year":"2023","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148293_bb0180","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nchembio.1750","article-title":"Lipid vesicles trigger \u03b1-synuclein aggregation by stimulating primary nucleation","volume":"11","author":"Galvagnion","year":"2015","journal-title":"Nat. Chem. Biol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.148293_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003537","article-title":"Cross-seeding of misfolded proteins: implications for etiology and pathogenesis of protein misfolding diseases","volume":"9","author":"Morales","year":"2013","journal-title":"PLoS Pathog."},{"issue":"24","key":"10.1016\/j.ijbiomac.2025.148293_bb0190","doi-asserted-by":"crossref","first-page":"7080","DOI":"10.1039\/D2SC01278B","article-title":"Molecular mechanisms of amyloid formation in living systems","volume":"13","author":"Sinnige","year":"2022","journal-title":"Chem. Sci."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.148293_bb0195","doi-asserted-by":"crossref","first-page":"7606","DOI":"10.1039\/C4CP05563B","article-title":"On the lag phase in amyloid fibril formation","volume":"17","author":"Arosio","year":"2015","journal-title":"Phys. Chem. Chem. Phys."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.148293_bb0200","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1002\/prot.22762","article-title":"Insight into the correlation between lag time and aggregation rate in the kinetics of protein aggregation","volume":"78","author":"Auer","year":"2010","journal-title":"Proteins: structure, Function, and Bioinformatics"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148293_bb0205","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1021\/acsomega.0c05638","article-title":"Heparin accelerates the protein aggregation via the downhill polymerization mechanism: multi-spectroscopic studies to delineate the implications on proteinopathies","volume":"6","author":"Ahanger","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0210","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.636454","article-title":"Rationalizing the role of monosodium glutamate in the protein aggregation through biophysical approaches: potential impact on neurodegeneration","volume":"15","author":"Ahanger","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0215","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ijbiomac.2014.04.046","article-title":"Relationship between the initial rate of protein aggregation and the lag period for amorphous aggregation","volume":"68","author":"Borzova","year":"2014","journal-title":"Int. J. Biol. Macromol."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2025.148293_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2004.11.014","article-title":"Protein aggregation and its inhibition in biopharmaceutics","volume":"289","author":"Wang","year":"2005","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148293_bb0225","doi-asserted-by":"crossref","DOI":"10.1063\/1.3050295","article-title":"Simulations of nucleation and elongation of amyloid fibrils","volume":"130","author":"Zhang","year":"2009","journal-title":"J. Chem. Phys."},{"issue":"21","key":"10.1016\/j.ijbiomac.2025.148293_bb0230","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2216234120","article-title":"Formation of amyloid loops in brain tissues is controlled by the flexibility of protofibril chains","volume":"120","author":"Miller","year":"2023","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148293_bb0235","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1021\/jp9110794","article-title":"Assessing the stability of Alzheimer\u2019s amyloid protofibrils using molecular dynamics","volume":"114","author":"Lemkul","year":"2010","journal-title":"J. Phys. Chem. B"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148293_bb0240","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.tips.2014.12.004","article-title":"Supersaturation is a major driving force for protein aggregation in neurodegenerative diseases","volume":"36","author":"Ciryam","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148293_bb0245","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25051195","article-title":"Structure and aggregation mechanisms in amyloids","volume":"25","author":"Almeida","year":"2020","journal-title":"Molecules"},{"issue":"14","key":"10.1016\/j.ijbiomac.2025.148293_bb0250","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.3390\/molecules27144588","article-title":"Supersaturation-dependent formation of amyloid fibrils","volume":"27","author":"Goto","year":"2022","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148293_bb0255","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nrd3050","article-title":"Protein aggregation diseases: pathogenicity and therapeutic perspectives","volume":"9","author":"Aguzzi","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148293_bb0260","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2174\/092986606775338362","article-title":"Protein aggregation and its consequences for human disease","volume":"13","author":"Dobson","year":"2006","journal-title":"Protein Pept. Lett."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148293_bb0265","first-page":"1","article-title":"Protein aggregation and degradation mechanisms in neurodegenerative diseases","volume":"2","author":"Takalo","year":"2013","journal-title":"Am. J. Neurodegener. Dis."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148293_bb0270","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/j.bmcl.2013.01.089","article-title":"Recent developments in targeting protein misfolding diseases","volume":"23","author":"Denny","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148293_bb0275","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","article-title":"Hallmarks of neurodegenerative diseases","volume":"186","author":"Wilson","year":"2023","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148293_bb0280","doi-asserted-by":"crossref","first-page":"10","DOI":"10.33590\/emjneurol\/10314777","article-title":"Current concepts of neurodegenerative diseases","volume":"1","author":"Kovacs","year":"2014","journal-title":"Emj Neurol"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148293_bb0285","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3390\/ijms17020189","article-title":"Molecular pathological classification of neurodegenerative diseases: turning towards precision medicine","volume":"17","author":"Kovacs","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.148293_bb0290","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/s41593-018-0235-9","article-title":"Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases","volume":"21","author":"Soto","year":"2018","journal-title":"Nat. Neurosci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148293_bb0295","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1089\/dna.2014.2757","article-title":"Alzheimer\u2019s disease-related misfolded proteins and dysfunctional organelles on autophagy menu","volume":"34","author":"Correia","year":"2015","journal-title":"DNA Cell Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148293_bb0300","first-page":"3740461","article-title":"Current concepts of neurodegenerative mechanisms in Alzheimer\u2019s disease","volume":"2018","author":"Magalingam","year":"2018","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0305","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s12041-018-0962-4","article-title":"Neurofibrillary tangles mediated human neuronal tauopathies: insights from fly models","volume":"97","author":"Sarkar","year":"2018","journal-title":"J. Genet."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148293_bb0310","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0315","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/jnc.13691","article-title":"The clinical symptoms of Parkinson\u2019s disease","volume":"139","author":"Sveinbjornsdottir","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0320","first-page":"28","article-title":"Clinical neurology of Huntington's disease","volume":"45","author":"Kremer","year":"2002","journal-title":"Oxford monographs on medical genetics"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0325","series-title":"Behavioral neurobiology of Huntington\u2019s disease and Parkinson\u2019s disease","first-page":"33","article-title":"The neuropathology of Huntington\u2019s disease","author":"Waldvogel","year":"2015"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-5-40","article-title":"Huntington\u2019s disease: a clinical review","volume":"5","author":"Roos","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148293_bb0335","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/jnnp.71.3.310","article-title":"Neuropsychiatric aspects of Huntington\u2019s disease","volume":"71","author":"Paulsen","year":"2001","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148293_bb0340","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/neup.12355","article-title":"Creutzfeldt-jakob disease","volume":"37","author":"Iwasaki","year":"2017","journal-title":"Neuropathology"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148293_bb0345","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1750-3639.1995.tb00625.x","article-title":"Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases)","volume":"5","author":"Budka","year":"1995","journal-title":"Brain Pathol."},{"issue":"14","key":"10.1016\/j.ijbiomac.2025.148293_bb0350","doi-asserted-by":"crossref","first-page":"6244","DOI":"10.1128\/JVI.00144-16","article-title":"Analysis of conformational stability of abnormal prion protein aggregates across the spectrum of Creutzfeldt-Jakob disease prions","volume":"90","author":"Cescatti","year":"2016","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.148293_bb0355","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1080\/14737175.2021.1965881","article-title":"Neuroprotective effect and potential of cellular prion protein and its cleavage products for treatment of neurodegenerative disorders part I. a literature review","volume":"21","author":"Dexter","year":"2021","journal-title":"Expert. Rev. Neurother."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148293_bb0360","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/13506129.2016.1257986","article-title":"Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 nomenclature guidelines","volume":"23","author":"Sipe","year":"2016","journal-title":"Amyloid"},{"issue":"18","key":"10.1016\/j.ijbiomac.2025.148293_bb0365","doi-asserted-by":"crossref","first-page":"9989","DOI":"10.1073\/pnas.96.18.9989","article-title":"Amyloid diseases: abnormal protein aggregation in neurodegeneration","volume":"96","author":"Koo","year":"1999","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0370","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1385\/NMM:4:1-2:49","article-title":"Interactions of amyloidogenic proteins","volume":"4","author":"Giasson","year":"2003","journal-title":"NeuroMolecular Med."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148293_bb0375","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3233\/JAD-200306","article-title":"Short-chain fatty acids and lipopolysaccharide as mediators between gut dysbiosis and amyloid pathology in Alzheimer\u2019s disease","volume":"78","author":"Marizzoni","year":"2020","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148293_bb0380","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJM200008103430607","article-title":"Islet amyloid and type 2 diabetes mellitus","volume":"343","author":"H\u00f6ppener","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148293_bb0385","doi-asserted-by":"crossref","DOI":"10.3390\/genes12070955","article-title":"Ocular involvement in hereditary amyloidosis","volume":"12","author":"Minnella","year":"2021","journal-title":"Genes"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148293_bb0390","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/01.mol.0000245260.63505.4f","article-title":"Untangling the role of amyloid in atherosclerosis","volume":"17","author":"Howlett","year":"2006","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.arr.2023.102017","article-title":"A comprehensive review of protein misfolding disorders, underlying mechanism, clinical diagnosis, and therapeutic strategies","volume":"90","author":"Basha","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148293_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103487","article-title":"Hyperphosphorylated tau (p-tau) and drug discovery in the context of Alzheimer\u2019s disease and related tauopathies","volume":"28","author":"Moore","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0405","series-title":"Neurodegener. Dis.","first-page":"55","article-title":"Role of protein aggregation in neurodegenerative diseases","author":"Tutar","year":"2013"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148293_bb0410","first-page":"8","article-title":"Protein stability, folding, disaggregation and etiology of conformational malfunctions","volume":"2","author":"Moosavi-Movahedi","year":"2016","journal-title":"Biom. J."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148293_bb0415","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.bbadis.2013.01.008","article-title":"Crosstalk between diabetes and brain: glucagon-like peptide-1 mimetics as a promising therapy against neurodegeneration","volume":"1832","author":"Duarte","year":"2013","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease"},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.148293_bb0420","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.metabol.2014.05.012","article-title":"\u03b2-Cell function in type 2 diabetes","volume":"63","author":"Ferrannini","year":"2014","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148293_bb0425","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000521515","article-title":"Early insulin resistance, type 2 diabetes, and treatment options in childhood","volume":"95","author":"Polidori","year":"2022","journal-title":"Horm. Res. Paediatr."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148293_bb0430","first-page":"442","article-title":"Type 2 diabetes and its impact on the immune system","volume":"16","author":"Berbudi","year":"2020","journal-title":"Curr. Diabetes Rev."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148293_bb0435","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s13340-018-0347-1","article-title":"IAPP\/amylin and \u03b2-cell failure: implication of the risk factors of type 2 diabetes","volume":"9","author":"Kanatsuka","year":"2018","journal-title":"Diabetol. Int."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148293_bb0440","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1021\/acs.chemrev.0c00981","article-title":"Proteostasis of islet amyloid polypeptide: a molecular perspective of risk factors and protective strategies for type II diabetes","volume":"121","author":"Milardi","year":"2021","journal-title":"Chem. Rev."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.148293_bb0445","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.febslet.2013.01.017","article-title":"Mechanisms of islet amyloidosis toxicity in type 2 diabetes","volume":"587","author":"Abedini","year":"2013","journal-title":"FEBS Lett."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148293_bb0450","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.molmed.2012.03.005","article-title":"Protein misfolding and aggregation in cataract disease and prospects for prevention","volume":"18","author":"Moreau","year":"2012","journal-title":"Trends Mol. Med."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148293_bb0455","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1134\/S000629792203004X","article-title":"Protein aggregation and cataract: role of age-related modifications and mutations in \u03b1-crystallins","volume":"87","author":"Budnar","year":"2022","journal-title":"Biochem. Mosc."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148293_bb0460","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1134\/S0006297922020018","article-title":"Crystallins as important pathogenic targets for accumulation of structural damages resulting in protein aggregation and cataract development: introduction to this special issue of Biochemistry (Moscow)","volume":"87","author":"Yousefi","year":"2022","journal-title":"Biochem. Mosc."},{"issue":"15","key":"10.1016\/j.ijbiomac.2025.148293_bb0465","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1167\/iovs.19-27535","article-title":"Molecular processes implicated in human age-related nuclear cataract","volume":"60","author":"Truscott","year":"2019","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148293_bb0470","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/APO.0000000000000156","article-title":"Nanotechnology for the prevention and treatment of cataract","volume":"4","author":"Cetinel","year":"2015","journal-title":"The Asia-Pacific Journal of Ophthalmology"},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.148293_bb0475","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.tcb.2014.05.003","article-title":"Proteostasis impairment in protein-misfolding and-aggregation diseases","volume":"24","author":"Hipp","year":"2014","journal-title":"Trends Cell Biol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.148293_bb0480","doi-asserted-by":"crossref","first-page":"8593","DOI":"10.3390\/ijms24108593","article-title":"Cellular protein aggregates: formation, biological effects, and ways of elimination","volume":"24","author":"Wen","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"21","key":"10.1016\/j.ijbiomac.2025.148293_bb0485","doi-asserted-by":"crossref","first-page":"5910","DOI":"10.1073\/pnas.1605363113","article-title":"Enhancing protein stability with extended disulfide bonds","volume":"113","author":"Liu","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"22","key":"10.1016\/j.ijbiomac.2025.148293_bb0490","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228672","article-title":"Transthyretin stabilization: an emerging strategy for the treatment of Alzheimer\u2019s disease?","volume":"21","author":"Saponaro","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0495","series-title":"Alzheimer\u2019s Disease: Cellular and Molecular Aspects of Amyloid \u03b2","first-page":"351","article-title":"Amyloid inhibitors and \u03b2-sheet breakers","author":"Soto","year":"2005"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0500","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ijbiomac.2019.11.222","article-title":"Both beta sheet breaker and alpha helix forming pentapeptide inhibits protein fibrillation: implication for the treatment of amyloid disorders","volume":"143","author":"Siddiqi","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.148293_bb0505","doi-asserted-by":"crossref","DOI":"10.1111\/ejn.70110","article-title":"RNA-based therapies for neurodegenerative diseases targeting pathogenic proteins","volume":"61","author":"Rabbani","year":"2025","journal-title":"Eur. J. Neurosci."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148293_bb0510","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1021\/acs.molpharmaceut.1c00916","article-title":"Lipid-nanoparticle-based delivery of CRISPR\/Cas9 genome-editing components","volume":"19","author":"Kazemian","year":"2022","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148293_bb0515","doi-asserted-by":"crossref","first-page":"9039","DOI":"10.1038\/s41598-017-08324-z","article-title":"The molecular chaperones DNAJB6 and Hsp70 cooperate to suppress \u03b1-synuclein aggregation","volume":"7","author":"Aprile","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0520","series-title":"The Networking of Chaperones by Co-chaperones: Control of Cellular Protein Homeostasis","first-page":"243","article-title":"The Role of HSP70 and its Co-Chaperones in Protein Misfolding, Aggregation and Disease","author":"Duncan","year":"2014"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148293_bb0525","doi-asserted-by":"crossref","DOI":"10.1038\/s41531-025-00886-4","article-title":"Prasinezumab slows motor progression in Parkinsons disease: beyond the clinical data","volume":"11","author":"Xiao","year":"2025","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0530","first-page":"1","article-title":"Active immunotherapy options for Alzheimer\u2019s disease","volume":"6","author":"Winblad","year":"2014","journal-title":"Alzheimer\u2019s Res Ther"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148293_bb0535","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.3233\/JPD-212594","article-title":"Safety and tolerability of active immunotherapy targeting \u03b1-synuclein with PD03A in patients with early Parkinson\u2019s disease: a randomized, placebo-controlled, phase 1 study","volume":"11","author":"Poewe","year":"2021","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0540","doi-asserted-by":"crossref","first-page":"63","DOI":"10.14283\/jpad.2018.45","article-title":"AADvac1, an active immunotherapy for Alzheimer\u2019s disease and non Alzheimer tauopathies: an overview of preclinical and clinical development","volume":"6","author":"Novak","year":"2019","journal-title":"J. Prev Alzheimers Dis."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148293_bb0545","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153035","article-title":"Optimization of the all-D peptide D3 for a\u03b2 oligomer elimination","volume":"11","author":"Klein","year":"2016","journal-title":"PLoS One"},{"issue":"21","key":"10.1016\/j.ijbiomac.2025.148293_bb0550","doi-asserted-by":"crossref","first-page":"11471","DOI":"10.1080\/07391102.2023.2262599","article-title":"Computational investigation on the effect of the peptidomimetic inhibitors (NPT100-18A and NPT200-11) on the \u03b1-synuclein and lipid membrane interactions","volume":"42","author":"Das","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148293_bb0555","doi-asserted-by":"crossref","first-page":"13416","DOI":"10.1038\/srep13416","article-title":"Distinct partitioning of ALS associated TDP-43, FUS and SOD1 mutants into cellular inclusions","volume":"5","author":"Farrawell","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0560","series-title":"Site-Specific Protein Labeling: Methods and Protocols","first-page":"29","article-title":"Getting across the Cell Membrane: an Overview for Small Molecules, Peptides, and Proteins","author":"Yang","year":"2015"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0565","series-title":"Bioactive natural products in drug discovery","first-page":"609","article-title":"Modulation of cellular protein quality control pathways using small natural molecules","author":"Badhwar","year":"2020"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0570","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.sbi.2014.12.004","article-title":"Inhibition of protein aggregation and amyloid formation by small molecules","volume":"30","author":"Doig","year":"2015","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.148293_bb0575","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1002\/anie.201307761","article-title":"Small-molecule control of intracellular protein levels through modulation of the ubiquitin proteasome system","volume":"53","author":"Buckley","year":"2014","journal-title":"Angew. Chem. Int. Ed."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148293_bb0580","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1074\/jbc.M404751200","article-title":"Curcumin inhibits formation of amyloid \u03b2 oligomers and fibrils, binds plaques, and reduces amyloid in vivo","volume":"280","author":"Yang","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0585","unstructured":"R.P. Weinberg, V.V. Koledova, A.J. Sinskey, C. Rha, Natural products for the therapy of proteinopathies underlying the neurodegenerative conditions: protein misfolding and fibrillization in Alzheimer's disease and Parkinson's disease."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0590","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1007\/s00018-018-2872-2","article-title":"Inhibition of protein misfolding and aggregation by natural phenolic compounds","volume":"75","author":"Dhouafli","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148293_bb0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101005","article-title":"Antioxidant berberine-derivative inhibits multifaceted amyloid toxicity","volume":"23","author":"Rajasekhar","year":"2020","journal-title":"Iscience"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148293_bb0600","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1038\/srep05648","article-title":"Effects of several quinones on insulin aggregation","volume":"4","author":"Gong","year":"2014","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148293_bb0605","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4161\/pri.4.1.10889","article-title":"Pyrroloquinoline quinone inhibits the fibrillation of amyloid proteins","volume":"4","author":"Kim","year":"2010","journal-title":"Prion"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148293_bb0610","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1021\/accountsmr.1c00193","article-title":"Inhibiting protein aggregation by small molecule-based colloidal nanoparticles","volume":"3","author":"Debnath","year":"2021","journal-title":"Accounts of materials research"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0615","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.phrs.2019.03.023","article-title":"Carbon nanomaterials and amyloid-beta interactions: potentials for the detection and treatment of Alzheimer\u2019s disease?","volume":"143","author":"Mohajeri","year":"2019","journal-title":"Pharmacol. Res."},{"issue":"13","key":"10.1016\/j.ijbiomac.2025.148293_bb0620","doi-asserted-by":"crossref","first-page":"5042","DOI":"10.1021\/ja111001v","article-title":"Unfolding the conformational behavior of peptide dendrimers: insights from molecular dynamics simulations","volume":"133","author":"Filipe","year":"2011","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148293_bb0625","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.nbd.2005.02.003","article-title":"Trehalose differentially inhibits aggregation and neurotoxicity of beta-amyloid 40 and 42","volume":"20","author":"Liu","year":"2005","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148293_bb0630","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1021\/acsanm.7b00245","article-title":"Inhibition of protein aggregation by iron oxide nanoparticles conjugated with glutamine-and proline-based osmolytes","volume":"1","author":"Pradhan","year":"2018","journal-title":"ACS Applied Nano Materials"},{"issue":"46","key":"10.1016\/j.ijbiomac.2025.148293_bb0635","doi-asserted-by":"crossref","first-page":"11084","DOI":"10.1021\/bi900649t","article-title":"Mechanisms of protein stabilization and prevention of protein aggregation by glycerol","volume":"48","author":"Vagenende","year":"2009","journal-title":"Biochemistry"},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.148293_bb0640","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.bbapap.2018.07.003","article-title":"Effect of polyols on the structure and aggregation of recombinant human \u03b3-Synuclein, an intrinsically disordered protein","volume":"1866","author":"Roy","year":"2018","journal-title":"Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics"},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.148293_bb0645","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1021\/bi052167g","article-title":"TMAO promotes fibrillization and microtubule assembly activity in the C-terminal repeat region of tau","volume":"45","author":"Scaramozzino","year":"2006","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148293_bb0650","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3233\/JAD-2009-1063","article-title":"Clioquinol decreases amyloid-\u03b2 burden and reduces working memory impairment in a transgenic mouse model of Alzheimer\u2019s disease","volume":"17","author":"Grossi","year":"2009","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148293_bb0655","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1021\/acs.molpharmaceut.0c00474","article-title":"Challenges and opportunities of deferoxamine delivery for treatment of Alzheimer\u2019s disease, Parkinson\u2019s disease, and intracerebral hemorrhage","volume":"18","author":"Farr","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0660","series-title":"Importance of Methionine 35 in Free Radical-Associated Mechanisms of Alzheimer\u2019s Amyloid beta-Peptide Neurotoxicity, and Experimental Rationale for the Use of Antioxidants as Therapeutic Intervention in Alzheimer\u2019s Disease","author":"Kanski","year":"2001"},{"issue":"27","key":"10.1016\/j.ijbiomac.2025.148293_bb0665","doi-asserted-by":"crossref","first-page":"6522","DOI":"10.1021\/bi900343n","article-title":"Protective effects of L-and D-carnosine on \u03b1-crystallin amyloid fibril formation: implications for cataract disease","volume":"48","author":"Attanasio","year":"2009","journal-title":"Biochemistry"},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.148293_bb0670","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1021\/acschemneuro.1c00104","article-title":"From small molecules to synthesized polymers: potential role in combating amyloidogenic disorders","volume":"12","author":"Ghosh","year":"2021","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148293_bb0675","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3181\/00379727-145-37742","article-title":"Inhibition of protein aggregation by vitamin E and selenium","volume":"145","author":"Taylor","year":"1974","journal-title":"Proc. Soc. Exp. Biol. Med."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148293_bb0680","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3390\/ijms20040879","article-title":"The effectiveness of vitamin E treatment in Alzheimer\u2019s disease","volume":"20","author":"Lloret","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0685","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijbiomac.2016.05.014","article-title":"Challenges with osmolytes as inhibitors of protein aggregation: can nucleic acid aptamers provide an answer?","volume":"100","author":"Patel","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148293_bb0690","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/jm8012823","article-title":"Discovery of innovative small molecule therapeutics","volume":"52","author":"Abou-Gharbia","year":"2009","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148293_bb0695","doi-asserted-by":"crossref","DOI":"10.3390\/cells9030589","article-title":"Small molecule Wnt pathway modulators from natural sources: history, state of the art and perspectives","volume":"9","author":"Blagodatski","year":"2020","journal-title":"Cells"},{"issue":"22","key":"10.1016\/j.ijbiomac.2025.148293_bb0700","doi-asserted-by":"crossref","first-page":"8329","DOI":"10.1021\/jo0610053","article-title":"Small molecule natural products in the discovery of therapeutic agents: the synthesis connection","volume":"71","author":"Wilson","year":"2006","journal-title":"J. Organomet. Chem."},{"issue":"28","key":"10.1016\/j.ijbiomac.2025.148293_bb0705","doi-asserted-by":"crossref","first-page":"9482","DOI":"10.1080\/10408398.2022.2067830","article-title":"Chemical aspects of polyphenol-protein interactions and their antibacterial activity","volume":"63","author":"Nassarawa","year":"2023","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"3\u20134","key":"10.1016\/j.ijbiomac.2025.148293_bb0710","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.tifs.2003.09.017","article-title":"Characterization of protein\u2013polyphenol interactions","volume":"15","author":"Papadopoulou","year":"2004","journal-title":"Trends Food Sci. Technol."},{"issue":"31","key":"10.1016\/j.ijbiomac.2025.148293_bb0715","doi-asserted-by":"crossref","first-page":"20309","DOI":"10.1021\/acsami.6b06853","article-title":"Efficient inhibition of protein aggregation, disintegration of aggregates, and lowering of cytotoxicity by green tea polyphenol-based self-assembled polymer nanoparticles","volume":"8","author":"Debnath","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0720","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.806470","article-title":"Dietary polyphenols and their role in oxidative stress-induced human diseases: insights into protective effects, antioxidant potentials and mechanism (s) of action","volume":"13","author":"Rudrapal","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148293_bb0725","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3390\/antiox11020197","article-title":"Effects of natural polyphenols on oxidative stress-mediated blood-brain barrier dysfunction","volume":"11","author":"Kim","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0730","first-page":"1","article-title":"Polyphenols and antioxidant activity in pseudocereals and their products","volume":"186","author":"\u0160krov\u00e1nkov\u00e1","year":"2020","journal-title":"Potravinarstvo Slovak Journal of Food Sciences"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0735","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173412","article-title":"Neuroprotective role of polyphenols against oxidative stress-mediated neurodegeneration","volume":"886","author":"Uddin","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148293_bb0740","doi-asserted-by":"crossref","DOI":"10.3390\/nu9050477","article-title":"The neuroprotective effects of phenolic acids: molecular mechanism of action","volume":"9","author":"Szwajgier","year":"2017","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148293_bb0745","doi-asserted-by":"crossref","DOI":"10.5812\/ipmn.117170","article-title":"Neuroprotective role of polyphenols in treatment of neurological disorders: a review","volume":"1","author":"Maqbool","year":"2021","journal-title":"Interventional Pain Medicine and Neuromodulation"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148293_bb0750","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2174\/1570159X20666221010113812","article-title":"Unveiling the potential of polyphenols as anti-amyloid molecules in Alzheimer\u2019s disease","volume":"21","author":"Kabir","year":"2023","journal-title":"Curr. Neuropharmacol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148293_bb0755","first-page":"1354","article-title":"Medicinal properties of turmeric (Curcuma longa L.): a review","volume":"6","author":"Verma","year":"2018","journal-title":"Int. J. Chem. Stud"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0760","series-title":"Bioactive Compounds in the Storage Organs of Plants","first-page":"395","article-title":"Bioactive compounds and biological activities of turmeric (Curcuma longa L.)","author":"Jyotirmayee","year":"2024"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148293_bb0765","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3390\/coatings11050519","article-title":"Curcumin: modern applications for a versatile additive","volume":"11","author":"Raduly","year":"2021","journal-title":"Coatings"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0770","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ijbiomac.2016.06.053","article-title":"Understanding curcumin-induced modulation of protein aggregation","volume":"100","author":"Ahmad","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"issue":"15","key":"10.1016\/j.ijbiomac.2025.148293_bb0775","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23158710","article-title":"Enhancing the amyloid-\u03b2 anti-aggregation properties of curcumin via arene-ruthenium (II) derivatization","volume":"23","author":"Cuccioloni","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148293_bb0780","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15030839","article-title":"Development of small molecules targeting \u03b1-synuclein aggregation: a promising strategy to treat Parkinson\u2019s disease","volume":"15","author":"Pe\u00f1a-D\u00edaz","year":"2023","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148293_bb0785","doi-asserted-by":"crossref","first-page":"1","DOI":"10.48130\/FMR-2022-0002","article-title":"Interaction between polyphenols and amyloids: from the view of prevention of protein misfolding disorders related diseases","volume":"2","author":"Ruan","year":"2022","journal-title":"Food Materials Research"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148293_bb0790","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1039\/D0MA00760A","article-title":"Review of the current state of protein aggregation inhibition from a materials chemistry perspective: special focus on polymeric materials","volume":"2","author":"Rajan","year":"2021","journal-title":"Materials Advances"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148293_bb0795","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1021\/acschemneuro.5b00214","article-title":"Curcumin attenuates amyloid-\u03b2 aggregate toxicity and modulates amyloid-\u03b2 aggregation pathway","volume":"7","author":"Thapa","year":"2016","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0800","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1208\/s12248-012-9444-4","article-title":"Highly stabilized curcumin nanoparticles tested in an in vitro blood\u2013brain barrier model and in Alzheimer\u2019s disease Tg2576 mice","volume":"15","author":"Cheng","year":"2013","journal-title":"AAPS J."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148293_bb0805","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2174\/156720508784533295","article-title":"Fiber diffraction as a screen for amyloid inhibitors","volume":"5","author":"Kirschner","year":"2008","journal-title":"Curr. Alzheimer Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148293_bb0810","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/jnr.20025","article-title":"Curcumin has potent anti-amyloidogenic effects for Alzheimer\u2019s \u03b2-amyloid fibrils in vitro","volume":"75","author":"Ono","year":"2004","journal-title":"J. Neurosci. Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148293_bb0815","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061287","article-title":"Uncovering the neuroprotective mechanisms of curcumin on transthyretin amyloidosis","volume":"20","author":"Ferreira","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0820","first-page":"1","article-title":"Inhibition of \u03b1-synuclein fibrillation by curcumin and difluoro boron derivatized curcumin complexes in aqueous environment","volume":"405","author":"Shaikh","year":"2024","journal-title":"J. Mol. Liq."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.148293_bb0825","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.bpj.2017.02.043","article-title":"Curcumin dictates divergent fates for the central salt bridges in amyloid-\u03b240 and amyloid-\u03b242","volume":"112","author":"Chandra","year":"2017","journal-title":"Biophys. J."},{"issue":"05","key":"10.1016\/j.ijbiomac.2025.148293_bb0830","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1142\/S2737416522500193","article-title":"Development of pyrazole harbouring novel leads against \u03b2-amyloid protein fibrillation by in silico drug design","volume":"21","author":"Mishra","year":"2022","journal-title":"Journal of Computational Biophysics and Chemistry"},{"issue":"16","key":"10.1016\/j.ijbiomac.2025.148293_bb0835","doi-asserted-by":"crossref","first-page":"11122","DOI":"10.1074\/jbc.M113.519447","article-title":"Curcumin alters the salt bridge-containing turn region in amyloid \u03b2 (1\u201342) aggregates","volume":"289","author":"Mithu","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148293_bb0840","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1021\/acs.jcim.9b00561","article-title":"Interactions between curcumin derivatives and amyloid-\u03b2 fibrils: insights from molecular dynamics simulations","volume":"60","author":"Jakubowski","year":"2019","journal-title":"J. Chem. Inf. Model."},{"issue":"s1","key":"10.1016\/j.ijbiomac.2025.148293_bb0845","doi-asserted-by":"crossref","first-page":"S321","DOI":"10.3233\/JAD-200941","article-title":"Computational evaluation of interaction between curcumin derivatives and amyloid-\u03b2 monomers and fibrils: relevance to Alzheimer\u2019s disease","volume":"82","author":"Orjuela","year":"2021","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.148293_bb0850","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.bmc.2015.02.041","article-title":"\u03b2-sheet interfering molecules acting against \u03b2-amyloid aggregation and fibrillogenesis","volume":"23","author":"Francioso","year":"2015","journal-title":"Bioorg. Med. Chem."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148293_bb0855","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3233\/JAD-170512","article-title":"Protective effects of Indian spice curcumin against amyloid-\u03b2 in Alzheimer\u2019s disease","volume":"61","author":"Reddy","year":"2018","journal-title":"J Alzheimer\u2019s Dis"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0860","series-title":"Computational and Synthetic Approaches for the Development of New Agents in the Management of Oncological and Neurodegenerative Diseases","author":"Bucolo","year":"2023"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148293_bb0865","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/138161212798918995","article-title":"Curcumin: a potential neuroprotective agent in Parkinson\u2019s disease","volume":"18","author":"Mythri","year":"2012","journal-title":"Curr. Pharm. Des."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148293_bb0870","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1021\/acs.langmuir.3c03032","article-title":"Interactions of turmeric-and curcumin-functionalized gold nanoparticles with human serum albumin: exploration of protein Corona formation, binding, thermodynamics, and Antifibrillation studies","volume":"40","author":"Baruah","year":"2023","journal-title":"Langmuir"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148293_bb0875","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1080\/07391102.2020.1819421","article-title":"Investigation of binding interaction between human serum albumin with zirconium complex of curcumin and curcumin","volume":"40","author":"Dezhampanah","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148293_bb0880","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2174\/0929866522666150209150004","article-title":"Curcumin mitigates the fibrillation of human serum albumin and diminishes the formation of reactive oxygen species","volume":"22","author":"Mazaheri","year":"2015","journal-title":"Protein Pept. Lett."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148293_bb0885","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2174\/1570159X18666200522201123","article-title":"Therapeutic and mechanistic effects of curcumin in Huntington\u2019s disease","volume":"19","author":"Labanca","year":"2021","journal-title":"Curr. Neuropharmacol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148293_bb0890","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133206","article-title":"Curcumin protects \u03b2-lactoglobulin fibril formation and fibril-induced neurotoxicity in PC12cells","volume":"10","author":"Mazaheri","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0895","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10571-016-0362-3","article-title":"Reversal of beta-amyloid-induced neurotoxicity in PC12 cells by curcumin, the important role of ROS-mediated signaling and ERK pathway","volume":"37","author":"Fan","year":"2017","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0900","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00249-016-1141-2","article-title":"Biophysical characteristics of proteins and living cells exposed to the green tea polyphenol epigallocatechin-3-gallate (EGCg): review of recent advances from molecular mechanisms to nanomedicine and clinical trials","volume":"46","author":"Peter","year":"2017","journal-title":"Eur. Biophys. J."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148293_bb0905","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3390\/ijms24010340","article-title":"Therapeutic effects of green tea polyphenol (\u2212)-Epigallocatechin-3-Gallate (EGCG) in relation to molecular pathways controlling inflammation, oxidative stress, and apoptosis","volume":"24","author":"Mokra","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0910","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115820","article-title":"Tea-break with epigallocatechin gallate derivatives\u2013powerful polyphenols of great potential for medicine","volume":"261","author":"Bakun","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0915","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/978-3-319-18365-7_7","article-title":"The effect of (\u2212)-Epigallo-catechin-(3)-gallate on amyloidogenic proteins suggests a common mechanism","author":"Andrich","year":"2015","journal-title":"Natural Compounds as Therapeutic Agents for Amyloidogenic Diseases"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0920","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.brainres.2008.02.107","article-title":"Green tea epigallocatechin-3-gallate (EGCG) reduces \u03b2-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice","volume":"1214","author":"Rezai-Zadeh","year":"2008","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148293_bb0925","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/pro.3549","article-title":"Suppression, disaggregation, and modulation of \u03b3-Synuclein fibrillation pathway by green tea polyphenol EGCG","volume":"28","author":"Roy","year":"2019","journal-title":"Protein Sci."},{"issue":"19","key":"10.1016\/j.ijbiomac.2025.148293_bb0930","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1021\/acschemneuro.0c00381","article-title":"Potential role of natural polyphenols against protein aggregation toxicity: in vitro, in vivo, and clinical studies","volume":"11","author":"Henr\u00edquez","year":"2020","journal-title":"ACS Chem. Neurosci."},{"issue":"18","key":"10.1016\/j.ijbiomac.2025.148293_bb0935","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1093\/hmg\/ddl210","article-title":"Green tea (\u2212)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington\u2019s disease models","volume":"15","author":"Ehrnhoefer","year":"2006","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148293_bb0940","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/1028415X.2018.1484021","article-title":"Green tea infusion alleviates neurodegeneration induced by mutant huntingtin in Drosophila","volume":"23","author":"Varga","year":"2020","journal-title":"Nutr. Neurosci."},{"issue":"15","key":"10.1016\/j.ijbiomac.2025.148293_bb0945","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1021\/jp312573y","article-title":"Molecular mechanism of the inhibition of EGCG on the Alzheimer A\u03b21\u201342 dimer","volume":"117","author":"Zhang","year":"2013","journal-title":"J. Phys. Chem. B"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148293_bb0950","doi-asserted-by":"crossref","first-page":"12579","DOI":"10.1038\/s41598-020-69429-6","article-title":"EGCG impedes human tau aggregation and interacts with tau","volume":"10","author":"Sonawane","year":"2020","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.148293_bb0955","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.18632\/oncotarget.27963","article-title":"Epigallocatechin-3-gallate modulates tau Post-translational modifications and cytoskeletal network","volume":"12","author":"Sonawane","year":"2021","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.148293_bb0960","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1096\/fj.02-0712fje","article-title":"cDNA gene expression profile homology of antioxidants and their antiapoptotic and proapoptotic activities in human neuroblastoma cells","volume":"17","author":"Weinreb","year":"2003","journal-title":"FASEB J."},{"issue":"34","key":"10.1016\/j.ijbiomac.2025.148293_bb0965","doi-asserted-by":"crossref","first-page":"30574","DOI":"10.1074\/jbc.M202832200","article-title":"Involvement of protein kinase C activation and cell survival\/cell cycle genes in green tea polyphenol (\u2212)-epigallocatechin 3-gallate neuroprotective action","volume":"277","author":"Levites","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"17","key":"10.1016\/j.ijbiomac.2025.148293_bb0970","doi-asserted-by":"crossref","first-page":"7710","DOI":"10.1073\/pnas.0910723107","article-title":"EGCG remodels mature \u03b1-synuclein and amyloid-\u03b2 fibrils and reduces cellular toxicity","volume":"107","author":"Bieschke","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0975","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.fitote.2015.09.018","article-title":"Quercetin: a flavonol with multifaceted therapeutic applications?","volume":"106","author":"D\u2019Andrea","year":"2015","journal-title":"Fitoterapia"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148293_bb0980","doi-asserted-by":"crossref","first-page":"NP11-NP17","DOI":"10.1177\/2156587215610032","article-title":"Antioxidative properties and effect of quercetin and its glycosylated form (Rutin) on acetylcholinesterase and butyrylcholinesterase activities","volume":"21","author":"Ademosun","year":"2016","journal-title":"Journal of evidence-based complementary & alternative medicine"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0985","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.619667","article-title":"Natural compounds as inhibitors of a\u03b2 peptide aggregation: chemical requirements and molecular mechanisms","volume":"14","author":"Pagano","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0990","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ijbiomac.2019.07.081","article-title":"Nanobiocatalyst facilitated aglycosidic quercetin as a potent inhibitor of tau protein aggregation","volume":"138","author":"Kumar","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb0995","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s12035-014-8722-9","article-title":"Polyphenols as therapeutic molecules in Alzheimer\u2019s disease through modulating amyloid pathways","volume":"51","author":"Lakey-Beitia","year":"2015","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148293_bb1000","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.neuint.2012.10.001","article-title":"Vitamins K interact with N-terminus \u03b1-synuclein and modulate the protein fibrillization in vitro. Exploring the interaction between quinones and \u03b1-synuclein","volume":"62","author":"da Silva","year":"2013","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1005","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.lfs.2019.03.055","article-title":"Molecular mechanisms underlying protective role of quercetin in attenuating Alzheimer\u2019s disease","volume":"224","author":"Zaplatic","year":"2019","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148293_bb1010","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.3390\/molecules25061267","article-title":"Molecular insight into the therapeutic promise of flavonoids against Alzheimer\u2019s disease","volume":"25","author":"Uddin","year":"2020","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148293_bb1015","doi-asserted-by":"crossref","first-page":"6328","DOI":"10.3390\/ijms24076328","article-title":"The potential benefits of quercetin for brain health: a review of anti-inflammatory and neuroprotective mechanisms","volume":"24","author":"Chiang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148293_bb1020","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.bbagen.2012.12.027","article-title":"Oxidized quercetin inhibits \u03b1-synuclein fibrillization","volume":"1830","author":"Zhu","year":"2013","journal-title":"Biochimica et Biophysica Acta (BBA)-General Subjects"},{"issue":"19","key":"10.1016\/j.ijbiomac.2025.148293_bb1025","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1021\/acschemneuro.0c00528","article-title":"Inhibitors of \u03b1-synuclein fibrillation and oligomer toxicity in Rosa damascena: the all-pervading powers of flavonoids and phenolic glycosides","volume":"11","author":"Eskandari","year":"2020","journal-title":"ACS Chem. Neurosci."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148293_bb1030","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1021\/acschemneuro.8b00039","article-title":"Genistein: a dual inhibitor of both amyloid \u03b2 and human islet amylin peptides","volume":"9","author":"Ren","year":"2018","journal-title":"ACS Chem. Neurosci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148293_bb1035","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1021\/acschemneuro.9b00673","article-title":"Ginnalin a inhibits aggregation, reverses fibrillogenesis, and alleviates cytotoxicity of amyloid \u03b2 (1\u201342)","volume":"11","author":"Fan","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1040","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.phrs.2017.10.008","article-title":"Apigenin as neuroprotective agent: of mice and men","volume":"128","author":"Nabavi","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1045","series-title":"Alkaloids: chemistry, Biology, Ecology, and Applications","author":"Aniszewski","year":"2015"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1050","series-title":"Therapeutic use of medicinal plants and their extracts: volume 2: phytochemistry and bioactive compounds","first-page":"165","article-title":"Secondary metabolites: Secondary metabolic products consisting of C and H; C, H, and O; N, S, and P elements; and O\/N heterocycles","author":"Alamgir","year":"2018"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1055","doi-asserted-by":"crossref","first-page":"1011740","DOI":"10.3389\/fphar.2022.1011740","article-title":"Natural product-based pharmacological studies for neurological disorders","volume":"13","author":"Puri","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1060","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.biopha.2017.03.003","article-title":"Berberine inhibits palmitate-induced NLRP3 inflammasome activation by triggering autophagy in macrophages: a new mechanism linking berberine to insulin resistance improvement","volume":"89","author":"Zhou","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148293_bb1065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134142","article-title":"Therapeutic effect of berberine on Huntington\u2019s disease transgenic mouse model","volume":"10","author":"Jiang","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148293_bb1070","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1080\/14756360802399662","article-title":"A potential role of alkaloid extracts from Salsola species (Chenopodiaceae) in the treatment of Alzheimer\u2019s disease","volume":"24","author":"Tundis","year":"2009","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1075","series-title":"Modifications of Lysozyme by Substituted Benzoquinones","author":"Greve","year":"2015"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1080","series-title":"Quinones as neuroprotective agents","author":"Esper\u00f3n","year":"2023"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148293_bb1085","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.bbrc.2010.08.038","article-title":"In vitro antiamyloidogenic properties of 1, 4-naphthoquinones","volume":"400","author":"Bermejo-Besc\u00f3s","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"14","key":"10.1016\/j.ijbiomac.2025.148293_bb1090","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1111\/j.1742-4658.2005.04792.x","article-title":"Inhibition of \u03b1-synuclein fibrillization by dopamine analogs via reaction with the amino groups of \u03b1-synuclein: implication for dopaminergic neurodegeneration","volume":"272","author":"Li","year":"2005","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148293_bb1095","doi-asserted-by":"crossref","first-page":"8711","DOI":"10.1038\/s41598-019-45168-1","article-title":"Rosmarinic acid suppresses Alzheimer\u2019s disease development by reducing amyloid \u03b2 aggregation by increasing monoamine secretion","volume":"9","author":"Hase","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1100","series-title":"Progress in Molecular Biology and Translational Science","doi-asserted-by":"crossref","DOI":"10.1016\/bs.pmbts.2024.10.006","article-title":"Modulation of Conformational Integrity and Aggregation Propensity of \u03b1-Synuclein by Osmolytes: Implications in Therapeutic Intervention of Parkinson\u2019s Disease","author":"Ishfaq Ahmad Ahanger","year":"2025"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148293_bb1105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2161-1009.1000304","article-title":"Biological wonders of osmolytes: the need to know more","volume":"5","author":"Judy","year":"2016","journal-title":"Biochem. Anal. Biochem"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148293_bb1110","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ymeth.2004.03.022","article-title":"Effects of naturally occurring osmolytes on protein stability and solubility: issues important in protein crystallization","volume":"34","author":"Bolen","year":"2004","journal-title":"Methods"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148293_bb1115","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1006\/jmbi.2001.4819","article-title":"The osmophobic effect: natural selection of a thermodynamic force in protein folding","volume":"310","author":"Bolen","year":"2001","journal-title":"J. Mol. Biol."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2025.148293_bb1120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2009.09.007","article-title":"Role of naturally occurring osmolytes in protein folding and stability","volume":"491","author":"Kumar","year":"2009","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1125","series-title":"Cellular Osmolytes: From Chaperoning Protein Folding to Clinical Perspectives","first-page":"35","article-title":"Role of TMAO on Folding Behavior of Various Proteins Associated with Neurodegeneration","author":"Kumari","year":"2024"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1130","series-title":"Cellular Osmolytes: From Chaperoning Protein Folding to Clinical Perspectives","first-page":"121","article-title":"Modulation of Protein Aggregation\/Fibrillation by Osmolytes","author":"Bhat","year":"2017"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148293_bb1135","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.pneurobio.2006.11.004","article-title":"Nucleocytoplasmic trafficking and transcription effects of huntingtin in Huntington\u2019s disease","volume":"83","author":"Truant","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1140","series-title":"Cellular Osmolytes: From Chaperoning Protein Folding to Clinical Perspectives","first-page":"73","article-title":"Osmolytes as a Promising Therapeutic Strategy for Protein Aggregation Diseases","author":"Khan","year":"2024"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148293_bb1145","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nm985","article-title":"Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease","volume":"10","author":"Tanaka","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1150","doi-asserted-by":"crossref","unstructured":"R. K Chowhan, S. Mittal, T. A Dar, M. A Kamal, L. R Singh, Ignored avenues in alpha-synuclein associated proteopathy, CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-& Neurological Disorders) 13(7) (2014) 1246\u20131257.","DOI":"10.2174\/1871527313666140917121943"},{"issue":"44","key":"10.1016\/j.ijbiomac.2025.148293_bb1155","doi-asserted-by":"crossref","first-page":"17826","DOI":"10.1073\/pnas.1201802109","article-title":"Counteracting chemical chaperone effects on the single-molecule \u03b1-synuclein structural landscape","volume":"109","author":"Ferreon","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1160","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpc.2020.106422","article-title":"Disorder under stress: role of polyol osmolytes in modulating fibrillation and aggregation of intrinsically disordered proteins","volume":"264","author":"Verma","year":"2020","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1165","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ijbiomac.2016.10.023","article-title":"Polyols (glycerol and ethylene glycol) mediated amorphous aggregate inhibition and secondary structure restoration of metalloproteinase-conalbumin (ovotransferrin)","volume":"94","author":"Khan","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"issue":"19\u201320","key":"10.1016\/j.ijbiomac.2025.148293_bb1170","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1016\/j.ccr.2012.03.037","article-title":"Coordination of redox active metal ions to the amyloid precursor protein and to amyloid-\u03b2 peptides involved in Alzheimer disease. Part 1: an overview","volume":"256","author":"Hureau","year":"2012","journal-title":"Coord. Chem. Rev."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.148293_bb1175","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.4155\/fmc.09.121","article-title":"Synthetic and natural iron chelators: therapeutic potential and clinical use","volume":"1","author":"Hatcher","year":"2009","journal-title":"Future Med. Chem."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148293_bb1180","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3233\/JHD-120029","article-title":"PBT2 reduces toxicity in a C. elegans model of polyQ aggregation and extends lifespan, reduces striatal atrophy and improves motor performance in the R6\/2 mouse model of Huntington's disease","volume":"1","author":"Cherny","year":"2012","journal-title":"Journal of Huntington's disease"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148293_bb1185","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/ejic.201601120","article-title":"Structures of the copper and zinc complexes of PBT2, a chelating agent evaluated as potential drug for neurodegenerative diseases","volume":"2017","author":"Nguyen","year":"2017","journal-title":"Eur. J. Inorg. Chem."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.148293_bb1190","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1474-4422(08)70167-4","article-title":"Safety, efficacy, and biomarker findings of PBT2 in targeting a\u03b2 as a modifying therapy for Alzheimer\u2019s disease: a phase IIa, double-blind, randomised, placebo-controlled trial","volume":"7","author":"Lannfelt","year":"2008","journal-title":"The Lancet Neurology"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148293_bb1195","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1474-4422(14)70262-5","article-title":"Safety, tolerability, and efficacy of PBT2 in Huntington\u2019s disease: a phase 2, randomised, double-blind, placebo-controlled trial","volume":"14","author":"Investigators","year":"2015","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148293_bb1200","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1196\/annals.1332.003","article-title":"The integrated role of desferrioxamine and phenserine targeted to an iron-responsive element in the APP-mRNA 5\u2032-untranslated region","volume":"1035","author":"Venti","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"14","key":"10.1016\/j.ijbiomac.2025.148293_bb1205","doi-asserted-by":"crossref","first-page":"7697","DOI":"10.3390\/ijms22147697","article-title":"Redox-active metal ions and amyloid-degrading enzymes in Alzheimer\u2019s disease","volume":"22","author":"Kim","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"30","key":"10.1016\/j.ijbiomac.2025.148293_bb1210","doi-asserted-by":"crossref","first-page":"18958","DOI":"10.1021\/acsomega.0c02235","article-title":"Rhodamine-based metal chelator: a potent inhibitor of metal-catalyzed amyloid toxicity","volume":"5","author":"Pradhan","year":"2020","journal-title":"ACS omega"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148293_bb1215","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3390\/pharmaceutics15020600","article-title":"A review of protein-and peptide-based chemical conjugates: past, present, and future","volume":"15","author":"Holz","year":"2023","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148293_bb1220","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3724\/abbs.2023081","article-title":"Coaggregation of polyglutamine (polyQ) proteins is mediated by polyQ-tract interactions and impairs cellular proteostasis: Coaggregation of polyQ proteins","volume":"55","author":"Hong","year":"2023","journal-title":"Acta Biochim. Biophys. Sin."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148293_bb1225","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s13311-013-0184-7","article-title":"Inhibition of protein misfolding\/aggregation using polyglutamine binding peptide QBP1 as a therapy for the polyglutamine diseases","volume":"10","author":"Popiel","year":"2013","journal-title":"Neurotherapeutics"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148293_bb1230","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1039\/D4MD00729H","article-title":"Peptide-based amyloid-beta aggregation inhibitors","volume":"16","author":"Sehra","year":"2025","journal-title":"RSC Med. Chem."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148293_bb1235","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1021\/acschemneuro.6b00006","article-title":"C-terminal fragment, A\u03b232\u201337, analogues protect against a\u03b2 aggregation-induced toxicity","volume":"7","author":"Bansal","year":"2016","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1240","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10989-011-9278-4","article-title":"The role of pro, Gly Lys, and Arg containing peptides on amyloid-beta aggregation","volume":"18","author":"Jagota","year":"2012","journal-title":"Int. J. Pept. Res. Ther."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1245","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pneurobio.2018.12.004","article-title":"Pivotal role of carnosine in the modulation of brain cells activity: multimodal mechanism of action and therapeutic potential in neurodegenerative disorders","volume":"175","author":"Caruso","year":"2019","journal-title":"Prog. Neurobiol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148293_bb1250","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1399-3011.2004.00156.x","article-title":"Inhibition of \u03b2-amyloid toxicity by short peptides containing N-methyl amino acids","volume":"63","author":"Cruz","year":"2004","journal-title":"J. Pept. Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148293_bb1255","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/j.bbadis.2018.03.023","article-title":"Identification of prion protein-derived peptides of potential use in Alzheimer's disease therapy","volume":"1864","author":"Nieznanska","year":"2018","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148293_bb1260","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1006\/bbrc.1996.1413","article-title":"Inhibition of Alzheimer\u2019s amyloidosis by peptides that prevent \u03b2-sheet conformation","volume":"226","author":"Soto","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"44","key":"10.1016\/j.ijbiomac.2025.148293_bb1265","doi-asserted-by":"crossref","first-page":"14711","DOI":"10.1002\/ange.201802979","article-title":"Designed macrocyclic peptides as nanomolar amyloid inhibitors based on minimal recognition elements","volume":"130","author":"Spanopoulou","year":"2018","journal-title":"Angew. Chem."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148293_bb1270","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.chembiol.2016.02.016","article-title":"Specific knockdown of endogenous tau protein by peptide-directed ubiquitin-proteasome degradation","volume":"23","author":"Chu","year":"2016","journal-title":"Cell Chem. Biol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148293_bb1275","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.chembiol.2020.03.010","article-title":"Specific knockdown of \u03b1-synuclein by peptide-directed proteasome degradation rescued its associated neurotoxicity","volume":"27","author":"Qu","year":"2020","journal-title":"Cell Chem. Biol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148293_bb1280","doi-asserted-by":"crossref","first-page":"949","DOI":"10.3233\/JPD-212671","article-title":"Role and mechanism of vitamin a metabolism in the pathophysiology of Parkinson\u2019s disease","volume":"11","author":"Marie","year":"2021","journal-title":"J. Parkinsons Dis."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148293_bb1285","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.nbd.2006.10.010","article-title":"Vitamin a potently destabilizes preformed \u03b1-synuclein fibrils in vitro: implications for Lewy body diseases","volume":"25","author":"Ono","year":"2007","journal-title":"Neurobiol. Dis."},{"issue":"28","key":"10.1016\/j.ijbiomac.2025.148293_bb1290","doi-asserted-by":"crossref","first-page":"8639","DOI":"10.1021\/bi060323t","article-title":"Secondary structure and interfacial aggregation of amyloid-\u03b2 (1\u201340) on sodium dodecyl sulfate micelles","volume":"45","author":"Rangachari","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1295","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.physb.2006.05.128","article-title":"Contrast variation SANS for the solution structure of the \u03b2-amyloid peptide 1\u201340 influenced by SDS surfactants","volume":"385","author":"Jeng","year":"2006","journal-title":"Phys. B Condens. Matter"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1300","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.colsurfa.2016.01.051","article-title":"Unfolding of human serum albumin by gemini and single-chain surfactants: a comparative study","volume":"495","author":"Zhang","year":"2016","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1305","series-title":"Application of an \u03b1Syn-Binding Aptamer to Reduce Protein Aggregation in a Cell Model of Parkinson\u2019s Disease-Associated Pathology","author":"Harris","year":"2024"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148293_bb1310","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/10408363.2019.1711359","article-title":"Methods for detecting toxic \u03b1-synuclein species as a biomarker for Parkinson\u2019s disease","volume":"57","author":"O\u2019Hara","year":"2020","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1315","doi-asserted-by":"crossref","first-page":"1584588","DOI":"10.3389\/fchem.2025.1584588","article-title":"Toxicity mechanism analysis of cGAS-STING-TBK1 signaling pathway small molecule modulator based on network toxicology and molecular docking strategy: quinacrine acetate as an example","volume":"13","author":"Zhu","year":"2025","journal-title":"Front. Chem."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1320","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116906","article-title":"The evolution of small-molecule Akt inhibitors from hit to clinical candidate","volume":"279","author":"Tian","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148293_bb1325","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41392-020-00315-3","article-title":"Recent advances in the development of protein\u2013protein interactions modulators: mechanisms and clinical trials","volume":"5","author":"Lu","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148293_bb1330","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.molmed.2015.11.005","article-title":"Small molecule modulators of pre-mRNA splicing in cancer therapy","volume":"22","author":"Salton","year":"2016","journal-title":"Trends Mol. Med."},{"issue":"16","key":"10.1016\/j.ijbiomac.2025.148293_bb1335","doi-asserted-by":"crossref","first-page":"12991","DOI":"10.1074\/jbc.M007859200","article-title":"Comparative analysis of amyloid-\u03b2 chemical structure and amyloid plaque morphology of transgenic mouse and Alzheimer\u2019s disease brains","volume":"276","author":"Kuo","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148293_bb1340","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.cell.2015.05.023","article-title":"Advancing biological understanding and therapeutics discovery with small-molecule probes","volume":"161","author":"Schreiber","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1345","series-title":"Handbook of Nonmedical Applications of Liposomes","first-page":"1","article-title":"Introduction on the History of Liposomes","author":"Lasic","year":"2023"},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.148293_bb1350","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3109\/1061186X.2013.837469","article-title":"Nanotechnology in cancer therapy","volume":"21","author":"Aslan","year":"2013","journal-title":"J. Drug Target."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148293_bb1355","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae\u2014the first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1360","series-title":"Discovery and history of quantum dots, quantum dots based nanocomposites: design, Fabrication and Emerging Applications","first-page":"13","author":"Reddy","year":"2024"},{"issue":"15","key":"10.1016\/j.ijbiomac.2025.148293_bb1365","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/adma.200500786","article-title":"Quantum dots in biological and biomedical research: recent progress and present challenges","volume":"18","author":"Klostranec","year":"2006","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1370","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.ejmech.2018.12.035","article-title":"Small molecule-drug conjugates: a novel strategy for cancer-targeted treatment","volume":"163","author":"Zhuang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.148293_bb1375","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1039\/C7CS00877E","article-title":"Peptide and protein nanoparticle conjugates: versatile platforms for biomedical applications","volume":"47","author":"Spicer","year":"2018","journal-title":"Chem. Soc. Rev."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148293_bb1380","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1021\/cr300143v","article-title":"Functionalizing nanoparticles with biological molecules: developing chemistries that facilitate nanotechnology","volume":"113","author":"Sapsford","year":"2013","journal-title":"Chem. Rev."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148293_bb1385","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-67469-6","article-title":"Glycated albumin precipitation using aptamer conjugated magnetic nanoparticles","volume":"10","author":"Fayazi","year":"2020","journal-title":"Sci. Rep."},{"issue":"21","key":"10.1016\/j.ijbiomac.2025.148293_bb1390","doi-asserted-by":"crossref","first-page":"17359","DOI":"10.1039\/C8NJ02441C","article-title":"An angiopep-2 functionalized nanoformulation enhances brain accumulation of tanshinone IIA and exerts neuroprotective effects against ischemic stroke","volume":"42","author":"Li","year":"2018","journal-title":"New J. Chem."},{"issue":"2\u20133","key":"10.1016\/j.ijbiomac.2025.148293_bb1395","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0168-3659(01)00248-6","article-title":"On the importance and mechanisms of burst release in matrix-controlled drug delivery systems","volume":"73","author":"Huang","year":"2001","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148293_bb1400","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1039\/C0CC04190D","article-title":"Acid-degradable solid-walled microcapsules for pH-responsive burst-release drug delivery","volume":"47","author":"Broaders","year":"2011","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1405","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jconrel.2016.03.004","article-title":"Fusion to an albumin-binding domain with a high affinity for albumin extends the circulatory half-life and enhances the in vivo antitumor effects of human TRAIL","volume":"228","author":"Li","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1410","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s10311-018-00841-1","article-title":"Nanocarriers for drug delivery applications","volume":"17","author":"Chamundeeswari","year":"2019","journal-title":"Environ. Chem. Lett."},{"issue":"16","key":"10.1016\/j.ijbiomac.2025.148293_bb1415","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23169361","article-title":"Lipid nanoparticles: promising treatment approach for Parkinson\u2019s disease","volume":"23","author":"Jagaran","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1420","article-title":"Evolution of lipid nanoparticles as charioteers of Alzheimer\u2019s disease therapeutics","volume":"41","author":"Chakraborty","year":"2024","journal-title":"Appl. Mater. Today"},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.148293_bb1425","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1111\/ejn.16336","article-title":"Lipid nanoparticle mediated small interfering RNA delivery as a potential therapy for Alzheimer\u2019s disease","volume":"59","author":"Ahmed","year":"2024","journal-title":"Eur. J. Neurosci."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148293_bb1430","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16050571","article-title":"Evaluation of the transport and binding of dopamine-loaded PLGA nanoparticles for the treatment of Parkinson\u2019s disease using in vitro model systems","volume":"16","author":"Danz","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1435","doi-asserted-by":"crossref","DOI":"10.1016\/j.colcom.2021.100579","article-title":"The roles of gold nanoparticles in the detection of amyloid-\u03b2 peptide for Alzheimer\u2019s disease","volume":"46","author":"Zhao","year":"2022","journal-title":"Colloid Interface Sci Commun"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148293_bb1440","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15010298","article-title":"Exosomes-based nanomedicine for neurodegenerative diseases: current insights and future challenges","volume":"15","author":"Cano","year":"2023","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148293_bb1445","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5497\/wjp.v3.i4.72","article-title":"Targeted approaches for HER2 breast cancer therapy: news from nanomedicine?","volume":"3","author":"Mazzucchelli","year":"2014","journal-title":"World Journal of Pharmacology"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148293_bb1450","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3390\/pharmaceutics11070325","article-title":"Nanoconjugation and encapsulation strategies for improving drug delivery and therapeutic efficacy of poorly water-soluble drugs","volume":"11","author":"Tran","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1455","series-title":"Biomedical applications of functionalized nanomaterials","first-page":"35","article-title":"Conjugation Chemistry Principles and Surface Functionalization of Nanomaterials","author":"Leiro","year":"2018"},{"issue":"16","key":"10.1016\/j.ijbiomac.2025.148293_bb1460","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1039\/D4NA00278D","article-title":"Carbon nanomaterials as carriers for the anti-cancer drug doxorubicin: a review on theoretical and experimental studies","volume":"6","author":"Gayathri","year":"2024","journal-title":"Nanoscale Advances"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148293_bb1465","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.3390\/molecules28062864","article-title":"Some nanocarrier\u2019s properties and chemical interaction mechanisms with flavones","volume":"28","author":"Esp\u00edndola","year":"2023","journal-title":"Molecules"},{"issue":"1915","key":"10.1016\/j.ijbiomac.2025.148293_bb1470","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1098\/rsta.2009.0273","article-title":"Surface modification, functionalization and bioconjugation of colloidal inorganic nanoparticles","volume":"368","author":"Sperling","year":"2010","journal-title":"Philos. Trans. R. Soc. A Math. Phys. Eng. Sci."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148293_bb1475","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3390\/bios13070723","article-title":"Streptavidin-conjugated DNA for the Boronate affinity-based detection of poly (ADP-ribose) Polymerase-1 with improved sensitivity","volume":"13","author":"Gao","year":"2023","journal-title":"Biosensors"},{"issue":"42","key":"10.1016\/j.ijbiomac.2025.148293_bb1480","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/26\/42\/422001","article-title":"Layer-by-layer assembly for biomedical applications in the last decade","volume":"26","author":"Gentile","year":"2015","journal-title":"Nanotechnology"},{"issue":"18","key":"10.1016\/j.ijbiomac.2025.148293_bb1485","doi-asserted-by":"crossref","first-page":"8883","DOI":"10.1021\/cr400531v","article-title":"Molecular interactions driving the layer-by-layer assembly of multilayers","volume":"114","author":"Borges","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1490","doi-asserted-by":"crossref","first-page":"9737","DOI":"10.12659\/MSM.918899","article-title":"Multifunctional polyethylene glycol (PEG)-poly (lactic-co-glycolic acid)(PLGA)-based nanoparticles loading doxorubicin and tetrahydrocurcumin for combined chemoradiotherapy of glioma","volume":"25","author":"Zhang","year":"2019","journal-title":"Medical Science Monitor: International Medical Journal of Experimental and Clinical Research"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1495","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.129750","article-title":"Nanoparticle drug conjugates treating microbial and viral infections: a review","volume":"1228","author":"Gatadi","year":"2021","journal-title":"J. Mol. Struct."},{"issue":"19","key":"10.1016\/j.ijbiomac.2025.148293_bb1500","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.2174\/092986712800784667","article-title":"Antibody-conjugated nanoparticles for therapeutic applications","volume":"19","author":"Cardoso","year":"2012","journal-title":"Curr. Med. Chem."},{"issue":"23","key":"10.1016\/j.ijbiomac.2025.148293_bb1505","doi-asserted-by":"crossref","first-page":"8428","DOI":"10.3390\/molecules27238428","article-title":"Formation of miRNA Nanoprobes\u2014conjugation approaches leading to the functionalization","volume":"27","author":"Vil\u00edmov\u00e1","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1510","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s40204-019-0106-9","article-title":"Effect of peptide-conjugated nanoparticles on cell lines","volume":"8","author":"Banerjee","year":"2019","journal-title":"Progress in biomaterials"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148293_bb1515","first-page":"226","article-title":"Targeted therapy of cancer: new prospects for antibodies and immunoconjugates","volume":"56","author":"Sharkey","year":"2006","journal-title":"CA Cancer J. Clin."},{"issue":"21","key":"10.1016\/j.ijbiomac.2025.148293_bb1520","doi-asserted-by":"crossref","first-page":"7726","DOI":"10.1021\/ja503010a","article-title":"Intracellular fate of spherical nucleic acid nanoparticle conjugates","volume":"136","author":"Wu","year":"2014","journal-title":"J. Am. Chem. Soc."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148293_bb1525","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1517\/17425247.2014.891582","article-title":"Gold nanoparticle conjugates: recent advances toward clinical applications","volume":"11","author":"Cao-Mil\u00e1n","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"issue":"31","key":"10.1016\/j.ijbiomac.2025.148293_bb1530","doi-asserted-by":"crossref","first-page":"10258","DOI":"10.1021\/ja801969b","article-title":"Magnetic nanoparticle\u2212 peptide conjugates for in vitro and in vivo targeting and extraction of cancer cells","volume":"130","author":"Scarberry","year":"2008","journal-title":"J. Am. Chem. Soc."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.148293_bb1535","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1039\/C2CS35396B","article-title":"Sweet carbon nanostructures: carbohydrate conjugates with carbon nanotubes and graphene and their applications","volume":"42","author":"Chen","year":"2013","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1540","series-title":"Enzyme Stabilization and Immobilization: Methods and Protocols","first-page":"165","article-title":"Enzyme\u2013Nanoparticle conjugates for biomedical applications","author":"Vertegel","year":"2011"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148293_bb1545","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10020057","article-title":"Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems","volume":"10","author":"Danaei","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1550","doi-asserted-by":"crossref","unstructured":"B. Mishra, K. Bharti, Nanomedicine Development: Methods, Scale-up, and Challenges, Nanomedicine, Nanotheranostics and Nanobiotechnology, CRC Press, pp. 10\u201321.","DOI":"10.1201\/9781003130055-2"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1555","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","article-title":"Nanoparticle-mediated brain drug delivery: overcoming blood\u2013brain barrier to treat neurodegenerative diseases","volume":"235","author":"Saraiva","year":"2016","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148293_bb1560","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/wnan.1263","article-title":"Targeted immunomodulation using antigen-conjugated nanoparticles","volume":"6","author":"McCarthy","year":"2014","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148293_bb1565","first-page":"1","article-title":"Toxicity of nanoparticles and an overview of current experimental models","volume":"20","author":"Bahadar","year":"2016","journal-title":"Iran. Biomed. J."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1570","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.taap.2016.01.005","article-title":"Understanding the immunogenicity and antigenicity of nanomaterials: past, present and future","volume":"299","author":"Ilinskaya","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148293_bb1575","doi-asserted-by":"crossref","first-page":"424","DOI":"10.7150\/ntno.86467","article-title":"Magnetic resonance imaging and iron-oxide nanoparticles in the era of personalized medicine","volume":"7","author":"Rahman","year":"2023","journal-title":"Nanotheranostics"},{"issue":"suppl_4","key":"10.1016\/j.ijbiomac.2025.148293_bb1580","doi-asserted-by":"crossref","first-page":"S411","DOI":"10.1098\/rsif.2010.0158.focus","article-title":"A review of nanoparticle functionality and toxicity on the central nervous system","volume":"7","author":"Yang","year":"2010","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1585","doi-asserted-by":"crossref","DOI":"10.1016\/j.onano.2022.100048","article-title":"Scale-up polymeric-based nanoparticles drug delivery systems: development and challenges","volume":"7","author":"Herdiana","year":"2022","journal-title":"OpenNano"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1590","series-title":"Organic-Based Nanomaterials in Food Packaging","first-page":"157","article-title":"Conjugated Organic Nanomaterials","author":"Tarafdar","year":"2024"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148293_bb1595","doi-asserted-by":"crossref","DOI":"10.1002\/VIW.20200190","article-title":"Consideration for the scale-up manufacture of nanotherapeutics\u2014a critical step for technology transfer","volume":"2","author":"Liu","year":"2021","journal-title":"View"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1600","series-title":"Pharmaceutical Regulation of Nanomedicines: Principles and Challenges, Universidade de Lisboa (Portugal)","author":"Lousa","year":"2024"},{"issue":"17","key":"10.1016\/j.ijbiomac.2025.148293_bb1605","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1039\/D0BM00558D","article-title":"The regulation of nanomaterials and nanomedicines for clinical application: current and future perspectives","volume":"8","author":"Foulkes","year":"2020","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1610","series-title":"Nanocarrier Vaccines: Biopharmaceutics-Based Fast Track Development","first-page":"465","article-title":"Regulatory Pathways for Nanocarrier Vaccine","author":"Gogoi","year":"2024"},{"issue":"20","key":"10.1016\/j.ijbiomac.2025.148293_bb1615","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.3390\/molecules29204854","article-title":"Enhancing drug solubility, bioavailability, and targeted therapeutic applications through magnetic nanoparticles","volume":"29","author":"Zhuo","year":"2024","journal-title":"Molecules"},{"issue":"37","key":"10.1016\/j.ijbiomac.2025.148293_bb1620","doi-asserted-by":"crossref","first-page":"15127","DOI":"10.1073\/pnas.1309566110","article-title":"Correlating preclinical animal studies and human clinical trials of a multifunctional, polymeric nanoparticle","volume":"110","author":"Eliasof","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"33","key":"10.1016\/j.ijbiomac.2025.148293_bb1625","doi-asserted-by":"crossref","first-page":"14541","DOI":"10.1073\/pnas.1006507107","article-title":"Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis","volume":"107","author":"Bhattacharyya","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"14","key":"10.1016\/j.ijbiomac.2025.148293_bb1630","doi-asserted-by":"crossref","first-page":"6361","DOI":"10.7150\/thno.46468","article-title":"Comparative study of preclinical mouse models of high-grade glioma for nanomedicine research: the importance of reproducing blood-brain barrier heterogeneity","volume":"10","author":"Brighi","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1635","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e29726","article-title":"Inorganic nanoparticle-cored dendrimers for biomedical applications: a review. 10.9","author":"Fateh","year":"2024","journal-title":"Heliyon"},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.148293_bb1640","doi-asserted-by":"crossref","first-page":"10554","DOI":"10.1021\/acsami.7b01886","article-title":"Sugar-terminated nanoparticle chaperones are 102\u2013105 times better than molecular sugars in inhibiting protein aggregation and reducing amyloidogenic cytotoxicity","volume":"9","author":"Pradhan","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1645","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/978-3-030-61985-5_12","article-title":"Nanoparticles as artificial chaperons suppressing protein aggregation: remedy in neurodegenerative diseases","author":"Tripathi","year":"2021","journal-title":"Biobased Nanotechnology for Green Applications"},{"issue":"19","key":"10.1016\/j.ijbiomac.2025.148293_bb1650","doi-asserted-by":"crossref","DOI":"10.1002\/admi.202001060","article-title":"Amyloid-mediated fabrication of organic\u2013inorganic hybrid materials and their biomedical applications","volume":"7","author":"Zhao","year":"2020","journal-title":"Adv. Mater. Interfaces"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148293_bb1655","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1166\/jns.2009.005","article-title":"Metal chelators coupled with nanoparticles as potential therapeutic agents for Alzheimer's disease","volume":"1","author":"Liu","year":"2009","journal-title":"Journal of nanoneuroscience"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148293_bb1660","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.neulet.2009.03.064","article-title":"Nanoparticle\u2013chelator conjugates as inhibitors of amyloid-\u03b2 aggregation and neurotoxicity: a novel therapeutic approach for Alzheimer disease","volume":"455","author":"Liu","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1665","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jcis.2017.06.093","article-title":"Iminodiacetic acid-conjugated nanoparticles as a bifunctional modulator against Zn2+\u2212mediated amyloid \u03b2-protein aggregation and cytotoxicity","volume":"505","author":"Liu","year":"2017","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1670","series-title":"Micronutrients and Brain Health","first-page":"399","article-title":"2Chapter 6 Iron and Monoamine Oxidase in Brain Function and Dysfunction: Development of Neuroprotective-Neurorescue Drugs","author":"Weinreb","year":"2009"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1675","series-title":"Nanoneuroscience and Nanoneuropharmacology","article-title":"Development of iron chelator\u2013nanoparticle conjugates as potential therapeutic agents for Alzheimer disease","volume":"97","author":"Sharma","year":"2009"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148293_bb1680","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0896-6273(01)00317-8","article-title":"Treatment with a copper-zinc chelator markedly and rapidly inhibits \u03b2-amyloid accumulation in Alzheimer's disease transgenic mice","volume":"30","author":"Cherny","year":"2001","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148293_bb1685","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/wnan.59","article-title":"Quinoline-n-butylcyanoacrylate-based nanoparticles for brain targeting for the diagnosis of Alzheimer\u2019s disease","volume":"2","author":"Kulkarni","year":"2010","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"issue":"2\u20133","key":"10.1016\/j.ijbiomac.2025.148293_bb1690","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jconrel.2005.07.024","article-title":"Targeted nanoparticles for drug delivery through the blood\u2013brain barrier for Alzheimer\u2019s disease","volume":"108","author":"Roney","year":"2005","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148293_bb1695","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ejpb.2004.07.009","article-title":"Novel d-penicillamine carrying nanoparticles for metal chelation therapy in Alzheimer\u2019s and other CNS diseases","volume":"59","author":"Cui","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"28","key":"10.1016\/j.ijbiomac.2025.148293_bb1700","doi-asserted-by":"crossref","first-page":"24126","DOI":"10.1021\/acsami.7b06510","article-title":"Poly (trehalose) nanoparticles prevent amyloid aggregation and suppress polyglutamine aggregation in a Huntington\u2019s disease model mouse","volume":"9","author":"Debnath","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"35","key":"10.1016\/j.ijbiomac.2025.148293_bb1705","doi-asserted-by":"crossref","first-page":"2003054","DOI":"10.1002\/adfm.202003054","article-title":"Recent advancements of nanomedicine in neurodegenerative disorders theranostics","volume":"30","author":"Mukherjee","year":"2020","journal-title":"Adv. Funct. Mater."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.148293_bb1710","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.1021\/acsabm.9b00518","article-title":"Quercetin encapsulated polymer nanoparticle for inhibiting intracellular polyglutamine aggregation","volume":"2","author":"Debnath","year":"2019","journal-title":"ACS Appl. Bio Mater."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148293_bb1715","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/biom9010022","article-title":"Combination of cell-penetrating peptides with nanoparticles for therapeutic application: a review","volume":"9","author":"Silva","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1720","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1007\/s11095-013-1005-8","article-title":"Angiopep-conjugated nanoparticles for targeted long-term gene therapy of Parkinson\u2019s disease","volume":"30","author":"Huang","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1725","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jconrel.2019.03.010","article-title":"Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)\/ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe\/PS1dE9 Alzheimer\u2019s disease mice model","volume":"301","author":"Cano","year":"2019","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.148293_bb1730","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.3390\/pharmaceutics13081183","article-title":"Solid lipid nanoparticles (SLNs): an advanced drug delivery system targeting brain through BBB","volume":"13","author":"Satapathy","year":"2021","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148293_bb1735","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9020430","article-title":"Curcumin\u2019s nanomedicine formulations for therapeutic application in neurological diseases","volume":"9","author":"Salehi","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1740","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.598617","article-title":"Quercetin-conjugated superparamagnetic iron oxide nanoparticles protect AlCl3-induced neurotoxicity in a rat model of Alzheimer\u2019s disease via antioxidant genes, APP gene, and miRNA-101","volume":"14","author":"Amanzadeh Jajin","year":"2021","journal-title":"Front. Neurosci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148293_bb1745","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3233\/JAD-170424","article-title":"Memantine for Alzheimer\u2019s disease: an updated systematic review and meta-analysis","volume":"60","author":"Kishi","year":"2017","journal-title":"J Alzheimer\u2019s Dis"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1750","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00702-016-1527-4","article-title":"Donepezil loaded PLGA-b-PEG nanoparticles: their ability to induce destabilization of amyloid fibrils and to cross blood brain barrier in vitro","volume":"124","author":"Baysal","year":"2017","journal-title":"J. Neural Transm."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148293_bb1755","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1073\/pnas.98.4.2089","article-title":"Galantamine: effect on nicotinic receptor binding, acetylcholinesterase inhibition, and learning","volume":"98","author":"Woodruff-Pak","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1760","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-018-0356-z","article-title":"Memantine loaded PLGA PEGylated nanoparticles for Alzheimer\u2019s disease: in vitro and in vivo characterization","volume":"16","author":"S\u00e1nchez-L\u00f3pez","year":"2018","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148293_bb1765","doi-asserted-by":"crossref","first-page":"25","DOI":"10.14283\/jpad.2022.84","article-title":"Buntanetap, a novel translational inhibitor of multiple neurotoxic proteins, proves to be safe and promising in both Alzheimer\u2019s and Parkinson\u2019s patients","volume":"10","author":"Fang","year":"2023","journal-title":"J. Prev Alzheimers Dis."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148293_bb1770","doi-asserted-by":"crossref","first-page":"800","DOI":"10.4103\/1673-5374.382233","article-title":"The pathogenic mechanism of TAR DNA-binding protein 43 (TDP-43) in amyotrophic lateral sclerosis","volume":"19","author":"Wang","year":"2024","journal-title":"Neural Regen. Res."},{"issue":"s1","key":"10.1016\/j.ijbiomac.2025.148293_bb1775","doi-asserted-by":"crossref","first-page":"S367","DOI":"10.3233\/JAD-220809","article-title":"Necroptosis and Alzheimer\u2019s disease: pathogenic mechanisms and therapeutic opportunities","volume":"94","author":"Zhang","year":"2023","journal-title":"J Alzheimer\u2019s Dis"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1780","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jphotobiol.2018.11.008","article-title":"A novel synthesis of selenium nanoparticles encapsulated PLGA nanospheres with curcumin molecules for the inhibition of amyloid \u03b2 aggregation in Alzheimer\u2019s disease","volume":"190","author":"Huo","year":"2019","journal-title":"J. Photochem. Photobiol. B Biol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.148293_bb1785","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0223781","article-title":"Anti-Alzheimer potential, metabolomic profiling and molecular docking of green synthesized silver nanoparticles of Lampranthus coccineus and Malephora lutea aqueous extracts","volume":"14","author":"Youssif","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148293_bb1790","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-18525-2","article-title":"Chiral gold nanoparticles enantioselectively rescue memory deficits in a mouse model of Alzheimer\u2019s disease","volume":"11","author":"Hou","year":"2020","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148293_bb1795","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.nano.2018.01.020","article-title":"Neuroprotective effect of gold nanoparticles composites in Parkinson\u2019s disease model","volume":"14","author":"Hu","year":"2018","journal-title":"Nanomedicine: nanotechnology, Biol. Med."},{"issue":"19","key":"10.1016\/j.ijbiomac.2025.148293_bb1800","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1001\/jama.2014.4310","article-title":"Effectiveness of paliperidone palmitate vs haloperidol decanoate for maintenance treatment of schizophrenia: a randomized clinical trial","volume":"311","author":"McEvoy","year":"2014","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148293_bb1805","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1089\/cap.2009.0007","article-title":"Efficacy and safety of dexmethylphenidate extended-release capsules administered once daily to children with attention-deficit\/hyperactivity disorder","volume":"19","author":"Childress","year":"2009","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1810","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s12325-013-0085-5","article-title":"Methylphenidate hydrochloride modified-release in adults with attention deficit hyperactivity disorder: a randomized double-blind placebo-controlled trial","volume":"31","author":"Huss","year":"2014","journal-title":"Adv. Ther."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.148293_bb1815","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.clinthera.2017.07.006","article-title":"A randomized phase I study to assess the effect of alcohol on the pharmacokinetics of an extended-release orally disintegrating tablet formulation of amphetamine in healthy adults","volume":"39","author":"Newcorn","year":"2017","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1820","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jaut.2014.05.005","article-title":"Immunomodulation neuroprotection and remyelination\u2013the fundamental therapeutic effects of glatiramer acetate: a critical review","volume":"54","author":"Aharoni","year":"2014","journal-title":"J. Autoimmun."},{"issue":"16","key":"10.1016\/j.ijbiomac.2025.148293_bb1825","doi-asserted-by":"crossref","first-page":"9082","DOI":"10.3390\/ijms22169082","article-title":"Nanomedicine for neurodegenerative disorders: focus on Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"22","author":"Jagaran","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148293_bb1830","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15051399","article-title":"Intranasal drug administration in Alzheimer-type dementia: towards clinical applications","volume":"15","author":"Tal\u00e9ns-Visconti","year":"2023","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.148293_bb1835","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1080\/13543784.2023.2252738","article-title":"CNM-Au8: an experimental agent for the treatment of amyotrophic lateral sclerosis (ALS)","volume":"32","author":"Bireley","year":"2023","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148293_bb1840","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-023-02236-z","article-title":"Evidence of brain target engagement in Parkinson\u2019s disease and multiple sclerosis by the investigational nanomedicine, CNM-Au8, in the REPAIR phase 2 clinical trials","volume":"21","author":"Ren","year":"2023","journal-title":"J. Nanobiotechnol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.148293_bb1845","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.addr.2012.01.020","article-title":"Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications","volume":"64","author":"Fleige","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.148293_bb1850","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2174\/0929866526666181212113855","article-title":"Quantum dots as promising theranostic tools against amyloidosis: a review","volume":"26","author":"Prabhu","year":"2019","journal-title":"Protein Pept. Lett."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148293_bb1855","doi-asserted-by":"crossref","first-page":"040","DOI":"10.53771\/ijlsra.2024.7.1.0060","article-title":"Revolutionizing drug delivery systems: nanotechnology-based approaches for targeted therapy","volume":"7","author":"Emeihe","year":"2024","journal-title":"International Journal of Life Science Research Archive"},{"issue":"01","key":"10.1016\/j.ijbiomac.2025.148293_bb1860","article-title":"Stimuli-responsive nanomaterials: innovations in on-demand drug release systems","volume":"19","author":"Mahammed","year":"2025","journal-title":"Asian Journal of Pharmaceutics (AJP)"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148293_bb1865","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15071928","article-title":"Research progress on stimulus-responsive polymer nanocarriers for cancer treatment","volume":"15","author":"Luo","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1870","article-title":"Intranasal administration of silibinin-loaded pullulan acetate nanocarriers: a pH-responsive approach for brain targeting in Alzheimer\u2019s disease","volume":"93","author":"Revdekar","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1875","first-page":"503","article-title":"Recent research of peptide-based hydrogel in nervous regeneration","volume":"40","author":"Xie","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1880","first-page":"567","article-title":"CRISPR\/Cas9 genome editing for neurodegenerative diseases","volume":"22","author":"Nojadeh","year":"2023","journal-title":"EXCLI J."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148293_bb1885","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s12033-021-00422-8","article-title":"CRISPR\/Cas-based modifications for therapeutic applications: a review","volume":"64","author":"Bharathkumar","year":"2022","journal-title":"Mol. Biotechnol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148293_bb1890","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.3390\/pharmaceutics14061252","article-title":"CRISPR-Cas9-based technology and its relevance to gene editing in Parkinson\u2019s disease","volume":"14","author":"Rahman","year":"2022","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148293_bb1895","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/pharmacy12020058","article-title":"A comparison of currently approved small interfering RNA (siRNA) medications to alternative treatments by costs, indications, and medicaid coverage","volume":"12","author":"Sehgal","year":"2024","journal-title":"Pharmacy"},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1900","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2025.177441","article-title":"SiRNA-based delivery systems: technologies, carriers, applications, and approved products","volume":"996","author":"Ghasemiyeh","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1905","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-4-9","article-title":"\u03b1-Synuclein and neuronal cell death","volume":"4","author":"Cookson","year":"2009","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1910","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2025.123563","article-title":"Critical role of micrornas in cellular quality control during brain aging and neurological disorders: interplay between autophagy and proteostasis","volume":"369","author":"Tamatta","year":"2025","journal-title":"Life Sci."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1915","first-page":"1","article-title":"Ai-driven design and optimization of nanoparticle-based drug delivery systems","volume":"18","author":"Kapoor","year":"2024","journal-title":"Sci. Eng. Health Stud."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1920","first-page":"1","article-title":"Artificial intelligence-aided rational design and prediction model for progesterone-loaded self-microemulsifying drug delivery system formulations","volume":"18","author":"Aumklad","year":"2024","journal-title":"Sci. Eng. Health Stud."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1925","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.sbi.2024.102776","article-title":"Artificial intelligence for drug discovery and development in Alzheimer\u2019s disease","volume":"85","author":"Qiu","year":"2024","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148293_bb1930","doi-asserted-by":"crossref","first-page":"bbab476","DOI":"10.1093\/bib\/bbab476","article-title":"Artificial intelligence in the prediction of protein\u2013ligand interactions: recent advances and future directions","volume":"23","author":"Dhakal","year":"2022","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1935","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1016\/j.csbj.2024.11.004","article-title":"Molecular dynamics simulations unveil the aggregation patterns and salting out of polyarginines at zwitterionic POPC bilayers in solutions of various ionic strengths","volume":"23","author":"Nguyen","year":"2024","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.ijbiomac.2025.148293_bb1940","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116691","article-title":"Advanced nanoparticle strategies for optimizing RNA therapeutic delivery in neurodegenerative disorders","volume":"175","author":"Naimi","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148293_bb1945","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3390\/jpm12050673","article-title":"The promise of nanotechnology in personalized medicine","volume":"12","author":"Alghamdi","year":"2022","journal-title":"Journal of personalized medicine"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148293_bb1950","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s42004-025-01491-5","article-title":"Towards precision medicine using biochemically triggered cleavable conjugation","volume":"8","author":"Parshad","year":"2025","journal-title":"Communications Chemistry"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025088506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025088506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T17:36:55Z","timestamp":1777484215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025088506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":390,"alternative-id":["S0141813025088506"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.148293","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nano-conjugation of small molecule modulators of protein aggregation: Enhancing the therapeutic precision","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.148293","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"148293"}}